The financials
Cooper Companies (The) by the numbers
Cooper Companies (The) (COO) reported revenue of $1.08B in Q2 2026 (quarter ended April 30, 2026), up 7.9% from the same quarter a year earlier. That came with a gross margin of 68% and net loss of $78M. For the full year FY2025, revenue was $4.09B (+5.1% year on year) and net income $375M. Its largest product in 2026-Q2 was Toric And Multifocal at $365M, 34% of the disclosed total, just ahead of Sphere Other at 33%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $1.08B | $1.00B | +7.9% |
| Gross profit | $735M | $679M | +8.3% |
| Operating income | −$31M | $185M | to a loss |
| Net income | −$78M | $88M | to a loss |
| Diluted EPS | −$0.40 | $0.44 | to a loss |
| Product | Revenue | Share |
|---|---|---|
| Toric And Multifocal | $365M | 34% |
| Sphere Other | $359M | 33% |
| Office And Surgical | $214M | 20% |
| Fertility | $144M | 13% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $1.08B (+5.6%)
Fertility grew +13% year on yearOffice And Surgical +4.1% year on year
Segment Latestquarter on quarteryear on year
- Toric And Multifocal$364.9M$364.9MQoQ +3.9%year on year +11%+3.9%+11%
- Sphere Other$358.6M$358.6MQoQ +4.3%year on year +5.1%+4.3%+5.1%
- Office And Surgical$214.2M$214.2MQoQ +5.8%year on year +4.1%+5.8%+4.1%
- Fertility$143.8M$143.8MQoQ +14%year on year +13%+14%+13%
Medical Instruments & Supplies
Ranks #19 of 27 by Smart Score